Here, we showed that ASTN functions on intrahepatic immune cells to inhibit NASH progression and liver fibrosis, specifically by suppressing F4/80lowCD11bhigh monocytes-derived macrophages (Figure 5). The gene discussed is ASTN1; the disease is metabolic dysfunction-associated steatohepatitis.